InnoCare Pharma (INCPF) Stock Price, News & Analysis

Company Overview

InnoCare Pharma Ltd is a China-based, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule targeted therapies for oncology. Headquartered in Shenzhen, Guangdong Province, the company leverages structure-based drug design and comprehensive preclinical screening to advance drug candidates that address high-unmet-need cancers.

The company’s development pipeline comprises multiple small-molecule inhibitors in various stages of preclinical and early clinical evaluation. InnoCare has prioritized programs that target solid tumors, including gastrointestinal and other hard-to-treat malignancies. Its research platform integrates in vitro and in vivo models to optimize lead compounds for potency, selectivity and safety.

Founded and headquartered in Shenzhen, InnoCare Pharma draws on a multidisciplinary team of medicinal chemists, biologists and clinical development experts. While its initial focus is on serving patients in Greater China, the company is exploring global partnerships and regulatory pathways to extend the reach of its oncology portfolio beyond domestic markets.

Key Stats

• Today's Range: $1.55 to $1.55
• 50-Day Range: $1.55 to $1.55
• 52-Week Range: $1.55 to $2.31
• Volume: N/A
• Average Volume: 550 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

Company Calendar

• Today: 7/21/2026
• Next Earnings (Estimated): 8/25/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:INCPF
• CIK: N/A
• Web: www.innocarepharma.com
• Phone: 861066609999
• Fax: N/A
• Employees: 1,089
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A